Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ARMP holding history

Armata Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARMP overviewAll 13F holders of ARMPFull Q2 2026 holdings

Shares (Q2 2026)
13,697
Value
$88.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ARMP by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,697$88.8K<0.1%+9,348+214.9%AddedHolders
Q1 20264,349$44.5K<0.1%+3,328+326.0%AddedHolders
Q4 20251,021$6.41K<0.1%+977+2,220.5%AddedHolders
Q3 202544$131<0.1%+43+4,300.0%AddedHolders
Q2 20251$2<0.1%−1,745−99.9%ReducedHolders
Q1 20251,746$2.55K<0.1%−4,567−72.3%ReducedHolders
Q4 20246,313$11.7K<0.1%+3,956+167.8%AddedHolders
Q3 20242,357$5.59K<0.1%+2,356+235,600.0%AddedHolders
Q2 20241$3<0.1%−766−99.9%ReducedHolders
Q1 2024767$3.21K<0.1%+766+76,600.0%AddedHolders
Q4 20231$3<0.1%−2,248−100.0%ReducedHolders
Q3 20232,249$6.75K<0.1%+2,248+224,800.0%AddedHolders
Q2 20231$1<0.1%−4,001−100.0%ReducedHolders
Q1 20234,002$6.68K<0.1%−2,916−42.2%ReducedHolders
Q4 20226,918$8.58K<0.1%+5,043+269.0%AddedHolders
Q3 20221,875$8.00K<0.1%−1,256−40.1%ReducedHolders
Q2 20223,131$12.0K<0.1%+390+14.2%AddedHolders
Q1 20222,741$13.0K<0.1%+705+34.6%AddedHolders
Q4 20212,036$11.0K<0.1%−866−29.8%ReducedHolders
Q3 20212,902$11.0K<0.1%+1,436+98.0%AddedHolders
Q2 20211,466$6.00K<0.1%−4,551−75.6%ReducedHolders
Q1 20216,017$29.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.